Tirzepatide is a dual receptor agonist of GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide):
1. Chronic weight management
It suppresses appetite and reduces calorie intake through the central nervous system, while improving metabolic indicators.
Obese patients (BMI >=30): average weight loss of 15%-22% (maximum dose 15 mg/week).
Overweight + complications (BMI >=27): It is also applicable to patients with hypertension and dyslipidemia.
2. Type 2 diabetes
Activate GLP-1 receptors → promote insulin secretion, inhibit glucagon, and delay gastric emptying.
Activate GIP receptors → enhance insulin sensitivity and reduce fat accumulation.
Significantly reduce HbA1c (glycosylated hemoglobin) (reduction of 1.8%-2.4%).
Assist weight loss (patients in clinical trials lost an average of 5%-11% weight).
Adults with type 2 diabetes (need to combine diet and exercise).
3. Potential uses in research
Non-alcoholic steatohepatitis (NASH): Improve liver inflammation and fibrosis.
Cardiovascular protection: May reduce cardiovascular risk in patients with type 2 diabetes (similar to GLP-1 drugs).
Polycystic ovary syndrome (PCOS): Improve hormone imbalance through weight loss.







High quality, competitive price, adequate stock and fast delivery competitive price.
Enterprise standard and 99% purity.
We are manufacturer and can provide high quality products with factory price.
1)Parcel can be sent out in 3 working days after payment. tracking number available.
2)Secure and discreet shipment. various transportation methods for your choice.
3)Customs pass rate 99%
Panas Tags: tirzepatide 30mg 10 vials weight loss compound, China tirzepatide 30mg 10 vials weight loss compound manufacturers, suppliers, factory






